US SB3635 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Republican 6-0)
Status: Introduced on May 6 2020 - 25% progression, died in committee
Action: 2020-05-06 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of, or reimbursement for, drugs manufactured in China, and for other purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Protecting Our Pharmaceutical Supply Chain from China Act of 2020

Sponsors


History

DateChamberAction
2020-05-06SenateRead twice and referred to the Committee on Finance.

Same As/Similar To

HB6482 (Related) 2020-07-13 - Referred to the Subcommittee on Oversight and Investigations.
SB3537 (Related) 2020-03-19 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback